California counties sue over painkiller marketing

by Paul Elias

Two California counties have filed a lawsuit accusing five drug companies of waging a campaign of deception to boost the sales of painkillers behind the nation's prescription drug addiction problem.

Orange and Santa Clara counties filed the suit Wednesday in Orange County Superior Court, alleging false advertising, and creating a public nuisance.

The five companies are Johnson & Johnson's Janssen Pharmaceuticals, Purdue Pharma, Actavis, Endo Health Solutions Inc., and Teva Pharmaceutical Industries' Cephalon Inc.

Much like the legal attack on tobacco companies two decades ago by many states, the current lawsuit accuses the of making misleading and false claims about the safety of products consumed annually by millions of Americans.

The lawsuit seeks to stop the marketing campaigns by the companies and demands unspecified damages.

5 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

Drug firms argue against $1.2B Arkansas judgment

Feb 27, 2014

(AP)—A lawyer for two drug companies told the Arkansas Supreme Court that the state improperly relied on federal regulations in a lawsuit that resulted in a $1.2 billion award over the companies' marketing of an antipsychotics ...

Teva says US is investigating Copaxone marketing

Feb 10, 2014

Teva Pharmaceutical Industries said Monday the federal government is investigating its marketing of its multiple sclerosis drug Copaxone and Parkinson's disease treatment Azilect.

Seattle taxi drivers sue ridesharing service

Mar 25, 2014

A Seattle-area taxi drivers organization has sued an app-based ridesharing service, alleging that Uber violates multiple laws and regulations, thus harming taxi drivers and the public.

Authorities in US sue Novartis in kickback scheme

Jan 09, 2014

Novartis Pharmaceuticals Corp. paid kickbacks to a specialty pharmacy in exchange for recommending refills of a blood transfusion drug it produces, according to an amended complaint filed Wednesday in a civil case brought ...

Recommended for you

FDA OKs Cubist antibiotic for serious infections

Dec 20, 2014

The Food and Drug Administration has approved a new medicine to fight complex infections in the abdomen and urinary tract, the fourth antibiotic the agency has approved since May.

Xtoro approved for swimmer's ear

Dec 18, 2014

(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.

Drug interaction identified for ondansetron, tramadol

Dec 18, 2014

(HealthDay)—In the early postoperative period, ondansetron is associated with increased requirements for tramadol consumption, according to a review and meta-analysis published online Dec. 10 in Anaesthesia.

New system targets germs in donated blood plasma

Dec 17, 2014

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.